Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anila Cara
Institutions:
Mayo Clinic,
University of Milan,
Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo
Observed institutions:
Mayo Clinic,
University of Milan,
Ospedale San Paolo,
Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo
ORCID:
0009-0001-6104-2891
Observed ORCID:
0009-0001-6104-2891
OpenAlex ID:
A5086867477
Future treatment of vascular calcification in chronic kidney disease
2023
·
Mario Cozzolino
, Federico Maffei Faccioli
, et al.
·
Expert Opinion on Pharmacotherapy
·
17
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab
2025
·
Maria J. Vargas-Brochero
, Elisabeth Lafaut
, et al.
·
Kidney International Reports
·
14
PDF
Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency
2021
·
Andrea Galassi
, Paola Ciceri
, et al.
·
Expert Opinion on Drug Safety
·
10
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index
2025
·
Maria J Vargas-Brochero
, Ilario Russo
, et al.
·
Nephrology Dialysis Transplantation
·
7
PDF
#2027 Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index
2025
·
Maria Vargas
, Ilario Russo
, et al.
·
Nephrology Dialysis Transplantation
·
3
Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns
2022
·
Andrea Galassi
, Anila Cara
, et al.
·
International Journal of Cardiology
·
2
Protocol kidney biopsy in the management of proliferative (class III/IV) lupus nephritis: barking up the wrong tree!
2026
·
Ladan Zand
, Gian Marco Berti
, et al.
·
Nephrology Dialysis Transplantation
·
1
PDF
Predictors of response and long-term tolerability of sparsentan in a real-world IgA nephropathy cohort
2026
·
Anila Cara
, Maria J Vargas-Brochero
, et al.
·
Clinical Kidney Journal
PDF
Rituximab With or Without Avacopan in ANCA-Associated Vasculitis With Severe Renal Involvement
2026
·
Cristián Juanet
, Isabel Hassi
, et al.
·
Kidney International Reports
A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy
2026
·
Maria J. Vargas-Brochero
, Anila Cara
, et al.
·
Kidney International
In Reply: Reassessing Cancer Attribution and Methodologic Limitations in PLA2R-Associated Membranous Nephropathy
2026
·
Ilario Russo
, Maria J. Vargas-Brochero
, et al.
·
Mayo Clinic Proceedings
Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reports
2026
·
Dalia Zubidat
, Maria Jose Soler
, et al.
·
Clinical Kidney Journal
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous Nephropathy
2026
·
Ilario Russo
, Maria J. Vargas-Brochero
, et al.
·
Mayo Clinic Proceedings
Long-Term Follow-Up of a Pure Class V Lupus Nephritis Cohort at Mayo Clinic
2025
·
Gian Marco Berti
, Anila Cara
, et al.
·
Journal of the American Society of Nephrology
Antiproteinuric Effect of SGLT2 Inhibitors in Nondiabetic Glomerulopathies Is Dependent on Body Mass Index
2025
·
Maria J. Vargas-Brochero
, Ilario Russo
, et al.
·
Journal of the American Society of Nephrology
Under Pressure: Rethinking Plasma Exchange in the Management of ANCA-Associated Vasculitis with Alveolar Hemorrhage
2025
·
Gian Marco Berti
, Samuel David Falde
, et al.
·
Journal of the American Society of Nephrology
Comorbidities, Biopsy Characteristics, and Kidney Outcomes in a Cohort of Patients with DNAJB9-Positive Fibrillary Glomerulonephritis
2025
·
Maria J. Vargas-Brochero
, Ilario Russo
, et al.
·
Journal of the American Society of Nephrology
Anti-dsDNA Serological Status in Proliferative Lupus Nephritis
2025
·
Ilario Russo
, Maria J. Vargas-Brochero
, et al.
·
Journal of the American Society of Nephrology
Laser Microdissection and Mass Spectrometry Analysis of Complement in Membranous Nephropathy (MN)
2025
·
Sanjeev Sethi
, Maria J. Vargas-Brochero
, et al.
·
Journal of the American Society of Nephrology
Double Trouble? When Myeloperoxidase (MPO) and Proteinase 3 (PR3) "Lie": A Cryoglobulinemia Case Report
2025
·
Anila Cara
, Gian Marco Berti
, et al.
·
Journal of the American Society of Nephrology
Association between Blood Flow Measured within 30 Days from Arteriovenous Access Creation and Thrombosis Risk
2025
·
Giacomo Scherini
, Lorenza Magagnoli
, et al.
·
Blood Purification
[Hypoxia-Inducible Factor Prolyl Hydroxylase Enzyme Inhibitors: A Novel Therapy for Anemia Treatment in CKD Patients].
2024
·
Andrea Stucchi
, Lorenza Magagnoli
, et al.
·
PubMed
#532 Association between blood flow measured within 30 days from AV access creation and the risk of thrombosis
2024
·
Lorenza Magagnoli
, Anila Cara
, et al.
·
Nephrology Dialysis Transplantation
PDF
#2242 mTORi: edging closer to targeted therapy in tuberous sclerosis complex
2024
·
Anila Cara
, Rossella Iatrino
, et al.
·
Nephrology Dialysis Transplantation
Show more works
View as search
Works count:
24
Citation count:
54
H-index:
4
I10-index:
3
Year
Topic
Type